IL-21 and T Cell Differentiation: Consider the Context

Trends in Immunology

Volumn 37, Issue 8, 2016, Pages 557-568

  Tian, Yuan ^a   Zajac, Allan J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN DERIVATIVE;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HOMEOSTASIS; HUMAN; INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTOPENIA; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TH9 CELL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; INTERLEUKINS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 84977104759     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.06.001     Document Type: Review

References (110)

1. 1 Coquet, J.M., et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178 (2007), 2827–2834.
2. 2 Yi, J.S., et al. Interleukin-21: a multifunctional regulator of immunity to infections. Microbes Infect. 12 (2010), 1111–1119.
3. 3 Spolski, R., Leonard, W.J., Interleukin-21: a double-edged sword with therapeutic potential. Nat. Rev. Drug Discov. 13 (2014), 379–395.
4. 4 Vegran, F., et al. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat. Immunol. 15 (2014), 758–766.
5. 5 Kim, H.P., et al. Calcium-dependent activation of interleukin-21 gene expression in T cells. J. Biol. Chem. 280 (2005), 25291–25297.
6. 6 Bauquet, A.T., et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10 (2009), 167–175.
7. 7 Pot, C., et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183 (2009), 797–801.
8. + T cells. J. Exp. Med. 205 (2008), 1369–1379.
9. 9 Elsaesser, H., et al. IL-21 is required to control chronic viral infection. Science 324 (2009), 1569–1572.
10. + T cell response to infection and memory T cell formation. Nat. Immunol. 14 (2013), 404–412.
11. 11 Zeng, R., et al. The molecular basis of IL-21-mediated proliferation. Blood 109 (2007), 4135–4142.
12. 12 Strengell, M., et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J. Immunol. 170 (2003), 5464–5469.
13. 13 Wurster, A.L., et al. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J. Exp. Med. 196 (2002), 969–977.
14. 14 Suto, A., et al. IL-21 inhibits IFN-γ production in developing Th1 cells through the repression of eomesodermin expression. J. Immunol. 177 (2006), 3721–3727.
15. 15 Kastirr, I., et al. IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells. J. Immunol. 193 (2014), 3322–3331.
16. 16 Pesce, J., et al. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Invest. 116 (2006), 2044–2055.
17. 17 Frohlich, A., et al. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109 (2007), 2023–2031.
18. 18 Lajoie, S., et al. IL-21 receptor signalling partially mediates Th2-mediated allergic airway responses. Clin. Exp. Allergy 44 (2014), 976–985.
19. + T cells promote type 2 immunity to house dust mites. Immunity 43 (2015), 318–330.
20. 20 Nurieva, R., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007), 480–483.
21. H17 cells. Nature 448 (2007), 484–487.
22. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8 (2007), 967–974.
23. 23 Attridge, K., et al. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood 119 (2012), 4656–4664.
24. 24 Schmitz, I., et al. IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection. PLoS Pathog., 9, 2013, e1003362.
25. 25 Spolski, R., et al. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 182 (2009), 2859–2867.
26. 26 Vogelzang, A., et al. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29 (2008), 127–137.
27. 27 Nurieva, R.I., et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29 (2008), 138–149.
28. 28 Liao, W., et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc. Natl Acad. Sci. U.S.A. 111 (2014), 3508–3513.
29. 29 Ding, Y., et al. Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice. Arthritis Rheumatol. 66 (2014), 2601–2612.
30. 30 Basu, R., et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37 (2012), 1061–1075.
31. + T cells. Nat. Commun. 5 (2014), 3753–3765.
32. 32 Lee, Y., et al. IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis. J. Clin. Invest. 125 (2015), 4011–4020.
33. 33 Yi, J.S., et al. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324 (2009), 1572–1576.
34. 34 Frohlich, A., et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324 (2009), 1576–1580.
35. + T cells. Immunity 35 (2011), 792–805.
36. + effector CD8 T cells during acute intracellular infection. J. Immunol. 196 (2016), 375–384.
37. 37 Yi, J.S., et al. IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. J. Immunol. 185 (2010), 4835–4845.
38. + T-cell responses. Eur. J. Immunol. 40 (2010), 3085–3096.
39. 39 Novy, P., et al. Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection. J. Immunol. 186 (2011), 2729–2738.
40. 40 King, I.L., et al. A nonredundant role for IL-21 receptor signaling in plasma cell differentiation and protective type 2 immunity against gastrointestinal helminth infection. J. Immunol. 185 (2010), 6138–6145.
41. 41 Coquet, J.M., et al. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180 (2008), 7097–7101.
42. 42 Sonderegger, I., et al. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur. J. Immunol. 38 (2008), 1833–1838.
43. 43 Linterman, M.A., et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207 (2010), 353–363.
44. 44 Zotos, D., et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207 (2010), 365–378.
45. 45 Poholek, A.C., et al. In vivo regulation of Bcl6 and T follicular helper cell development. J. Immunol. 185 (2010), 313–326.
46. 46 Eto, D., et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE, 6, 2011, e17739.
47. 47 Karnowski, A., et al. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J. Exp. Med. 209 (2012), 2049–2064.
48. + gamma delta T cell responses and production of IL-17 related cytokines in the lung at steady state and after influenza A virus infection. PLoS ONE, 10, 2015, e0120169.
49. 49 Tian, Y., et al. A context-dependent role for IL-21 in modulating the differentiation, distribution, and abundance of effector and memory CD8 T cell subsets. J. Immunol. 196 (2016), 2153–2166.
50. 50 Bettelli, E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006), 235–238.
51. 51 Victora, G.D., Nussenzweig, M.C., Germinal centers. Annu. Rev. Immunol. 30 (2012), 429–457.
52. 52 Crotty, S., T follicular helper cell differentiation, function, and roles in disease. Immunity 41 (2014), 529–542.
53. 53 Chung, Y., et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 17 (2011), 983–988.
54. + follicular regulatory T cells control the germinal center response. Nat. Med. 17 (2011), 975–982.
55. + follicular regulatory T cells. J. Immunol. 187 (2011), 4553–4560.
56. 56 Kaplan, M.H., et al. The development and in vivo function of T helper 9 cells. Nat. Rev. Immunol. 15 (2015), 295–307.
57. 57 Strengell, M., et al. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J. Immunol. 169 (2002), 3600–3605.
58. 58 Ballesteros-Tato, A., et al. T follicular helper cell plasticity shapes pathogenic T helper 2 cell-mediated immunity to inhaled house dust mite. Immunity 44 (2016), 259–273.
59. 59 Stritesky, G.L., et al. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 34 (2011), 39–49.
60. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434 (2005), 88–93.
61. 61 Zajac, A.J., et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188 (1998), 2205–2213.
62. 62 Kahan, S.M., et al. T cell exhaustion during persistent viral infections. Virology 479-480 (2015), 180–193.
63. 63 Wherry, E.J., Kurachi, M., Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15 (2015), 486–499.
64. high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J. Immunol. 174 (2005), 5926–5930.
65. 65 Shin, H., et al. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J. Exp. Med. 204 (2007), 941–949.
66. + T cells are associated with relative viral control in patients with chronic hepatitis B. Scand. J. Immunol. 78 (2013), 439–446.
67. 67 Publicover, J., et al. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J. Clin. Invest. 121 (2011), 1154–1162.
68. 68 Kared, H., et al. Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C. PLoS Pathog., 9, 2013, e1003422.
69. 69 Iannello, A., et al. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J. Immunol. 184 (2010), 114–126.
70. + T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J. Immunol. 185 (2010), 498–506.
71. 71 Williams, L.D., et al. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J. Virol. 85 (2011), 2316–2324.
72. + T cell function. J. Virol. 85 (2011), 733–741.
73. 73 White, L., et al. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood 109 (2007), 3873–3880.
74. 74 Pallikkuth, S., et al. Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication. Vaccine 29 (2011), 9229–9238.
75. + T cells represent peripheral Tfh cells with antigen-dependent helper functions. Immunity 44 (2016), 167–178.
76. 76 Xin, G., et al. A critical role of IL-21-induced BATF in sustaining CD8-T-cell-mediated chronic viral control. Cell Rep. 13 (2015), 1118–1124.
77. + T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31 (2009), 296–308.
78. + T cell exhaustion during chronic viral infection. Immunity 31 (2009), 309–320.
79. + T cells and memory responses. Immunity 31 (2009), 283–295.
80. 80 King, C., et al. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 (2004), 265–277.
81. 81 Casey, K.A., et al. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J. Immunol. 188 (2012), 4866–4875.
82. RM cells providing global skin immunity. Nature 483 (2012), 227–231.
83. 83 Masopust, D., et al. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J. Immunol. 176 (2006), 2079–2083.
84. 84 Cao, A.T., et al. Interleukin (IL)-21 promotes intestinal IgA response to microbiota. Mucosal Immunol. 8 (2015), 1072–1082.
85. 85 Hirahara, K., et al. Asymmetric action of STAT transcription factors drives transcriptional outputs and cytokine specificity. Immunity 42 (2015), 877–889.
86. + T cells. Proc. Natl Acad. Sci. U.S.A. 112 (2015), 9394–9399.
87. + CTL activity via the transcription factor T-bet. J. Immunol. 190 (2013), 3977–3984.
88. + T cells for adoptive immunotherapy. Blood 111 (2008), 5326–5333.
89. 89 Kwon, H., et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31 (2009), 941–952.
90. 90 Nurieva, R.I., et al. Bcl6 mediates the development of T follicular helper cells. Science 325 (2009), 1001–1005.
91. 91 Szabo, S.J., et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000), 655–669.
92. 92 Johnston, R.J., et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325 (2009), 1006–1010.
93. + T cell differentiation. Nat. Rev. Immunol. 12 (2012), 749–761.
94. + T cells depends on T cell factor-1 and lymphoid enhancer-binding factor-1. J. Immunol. 189 (2012), 2722–2726.
95. FH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat. Immunol. 16 (2015), 980–990.
96. 96 Yang, X.P., et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12 (2011), 247–254.
97. 97 Oestreich, K.J., et al. Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile. Nat. Immunol. 13 (2012), 405–411.
98. 98 Johnston, R.J., et al. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209 (2012), 243–250.
99. 99 Ray, J.P., et al. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity 40 (2014), 367–377.
100. 100 Hand, T.W., et al. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc. Natl Acad. Sci. U. S. A. 107 (2010), 16601–16606.
101. 101 Lin, J.X., et al. Critical role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity 36 (2012), 586–599.
102. + T cell responses. J. Immunol. 185 (2010), 2116–2124.
103. 103 Saleiro, D., Platanias, L.C., Intersection of mTOR and STAT signaling in immunity. Trends Immunol. 36 (2015), 21–29.
104. 104 Man, K., et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 14 (2013), 1155–1165.
105. + T cell expansion and effector differentiation. Immunity 39 (2013), 833–845.
106. 106 Parrish-Novak, J., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408 (2000), 57–63.
107. 107 Brenne, A.T., et al. Interleukin-21 is a growth and survival factor for human myeloma cells. Blood 99 (2002), 3756–3762.
108. 108 Menoret, E., et al. IL-21 stimulates human myeloma cell growth through an autocrine IGF-1 loop. J. Immunol. 181 (2008), 6837–6842.
109. 109 Scheeren, F.A., et al. IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood 111 (2008), 4706–4715.
110. 110 Timmerman, J.M., et al. A Phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disorders. Clin. Cancer Res. 18 (2012), 5752–5760.